NDC11 71209007904
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 71209-0079-04 | 71209-0079 |
| 71209-0079-4 | 71209-0079 |
| 71209-079-04 | 71209-079 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Cadila Pharmaceuticals Limited | c5416a9f-1dcc-4851-bbc0-6664d22fc8fa | 2024-08-05 | Boxed warning, Warnings, Adverse reactions | 71209-079-04 71209-079 71209007904 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.